Literature DB >> 17502585

Transvenous implantable cardioverter-defibrillator leads: the weakest link.

William H Maisel.   

Abstract

Mesh：

Year:  2007        PMID： 17502585     DOI： 10.1161/CIRCULATIONAHA.107.698597

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

Review 1.  Dual- versus single-coil implantable defibrillator leads: review of the literature.

Authors:  Jörg Neuzner; Jörg Carlsson
Journal:  Clin Res Cardiol       Date:  2012-01-10       Impact factor: 5.460

2.  [Lead survival and complications (except infections). Are we doing better nowadays?].

Authors:  Martin Seifert; Michael Neuss; Maren Schöpp; Cornel Koban; Christian Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-06

Review 3.  Subcutaneous chronic implantable defibrillation systems in humans.

Authors:  Riccardo Cappato; Warren M Smith; Margaret A Hood; Ian G Crozier; Luc Jordaens; Stefan G Spitzer; Andrey V Ardashev; Lucas Boersma; Pierpaolo Lupo; Andrew A Grace; Gust H Bardy
Journal:  J Interv Card Electrophysiol       Date:  2012-03-17       Impact factor: 1.900

4.  First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes.

Authors:  Giovanni B Forleo; Luigi Di Biase; Massimo Mantica; Germana Panattoni; Matteo Santamaria; Quintino Parisi; Domenico Sergi; Lida P Papavasileiou; Luca Santini; Claudio Tondo; Andrea Natale; Francesco Romeo
Journal:  J Interv Card Electrophysiol       Date:  2013-07-03       Impact factor: 1.900

5.  Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.

Authors:  Fernando Sérgio Oliva Souza; Vanessa Sepulvida Matos; Marcos Cesar Valério Almeida; Samuel Campagiotto Weiss; Lucas Henrique Borges Rodrigues; Pedro Augusto Gori Lima; Davi Bongiolo Mattos
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

6.  Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads.

Authors:  Amit Noheria; Shiva P Ponamgi; Christopher V Desimone; Vaibhav R Vaidya; Christopher A Aakre; Elisa Ebrille; Tiffany Hu; David O Hodge; Joshua P Slusser; Naser M Ammash; Charles J Bruce; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Europace       Date:  2015-03-12       Impact factor: 5.214

7.  Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.

Authors:  Daniel B Kramer; Laura A Hatfield; Deepa McGriff; Christopher R Ellis; Melanie T Gura; Michelle Samuel; Linda Kallinen Retel; Robert G Hauser
Journal:  J Am Heart Assoc       Date:  2015-05-29       Impact factor: 5.501

Review 8.  The entirely subcutaneous defibrillator (s-icd): state of the art and selection of the ideal candidate.

Authors:  Elia De Maria; Alina Olaru; Stefano Cappelli
Journal:  Curr Cardiol Rev       Date:  2015

Review 9.  Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.

Authors:  Rui Providência; Daniel B Kramer; Dominic Pimenta; Girish G Babu; Laura A Hatfield; Adam Ioannou; Jan Novak; Robert G Hauser; Pier D Lambiase
Journal:  J Am Heart Assoc       Date:  2015-10-30       Impact factor: 5.501

10.  Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.

Authors:  Jayanthi N Koneru; Paul W Jones; Eric F Hammill; Nicholas Wold; Kenneth A Ellenbogen
Journal:  J Am Heart Assoc       Date:  2018-05-10       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.